ANDROGEN AND PROGESTAGEN EFFECTS ON PLASMA-LIPIDS

被引:66
作者
BAGATELL, CJ
BREMNER, WJ
机构
[1] UNIV WASHINGTON, SCH MED, DEPT MED, SEATTLE, WA 98195 USA
[2] VET ADM MED CTR, MED SERV, SEATTLE, WA USA
关键词
D O I
10.1016/S0033-0620(95)80016-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Androgens are 19-carbon steroid rings. Progestagens include both 19-carbon and 21-carbon steroid rings; the 19-carbon progestagens are generally more androgenic than are the 21-carbon compounds. Both androgens and progestagens are physiological regulators of plasma lipids, particularly high-density lipoprotein (HDL) cholesterol. The structure of a particular hormonal preparation, as well as its route of administration, modulates its regularory effects. Both endogenous and exogenous androgens have a suppressive effect on HDL cholesterol in males, with little effect on other plasma lipoproteins. Oral and nonaromatizable androgens have a greater suppressive effect on HDL cholesterol, particularly on HDL2, than do aromatizable androgens. Cross-sectional studies in males generally show a positive relationship between serum T and plasma HDL levels; data in females suggest an inverse relationship between androgens and HDL cholesterol. Medroxy-progesterone acetate and related progestagens have a mild suppressive effect on plasma HDL levels. The C-19 compounds have a greater suppressive effect on HDL cholesterol and the HDL2 density subfraction. © 1995 W.B. Saunders Company.
引用
收藏
页码:255 / 271
页数:17
相关论文
共 125 条
[1]   REDUCTION OF LECITHIN-CHOLESTEROL ACYLTRANSFERASE, APOLIPOPROTEIN D AND THE LP(A) LIPOPROTEIN WITH THE ANABOLIC-STEROID STANOZOLOL [J].
ALBERS, JJ ;
TAGGART, HM ;
APPLEBAUMBOWDEN, D ;
HAFFNER, S ;
CHESNUT, CH ;
HAZZARD, WR .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 795 (02) :293-296
[2]   SERUM-LIPIDS IN POWER ATHLETES SELF-ADMINISTERING TESTOSTERONE AND ANABOLIC-STEROIDS [J].
ALEN, M ;
RAHKILA, P ;
MARNIEMI, J .
INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 1985, 6 (03) :139-144
[3]  
[Anonymous], 1990, Lancet, V336, P955
[4]   EFFECT OF ESTROGEN ON POST-HEPARIN LIPOLYTIC-ACTIVITY - SELECTIVE DECLINE IN HEPATIC TRIGLYCERIDE LIPASE [J].
APPLEBAUM, DM ;
GOLDBERG, AP ;
PYKALISTO, OJ ;
BRUNZELL, JD ;
HAZZARD, WR .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 59 (04) :601-608
[5]   THE DYSLIPOPROTEINEMIA OF ANABOLIC-STEROID THERAPY - INCREASE IN HEPATIC TRIGLYCERIDE LIPASE PRECEDES THE DECREASE IN HIGH-DENSITY LIPOPROTEIN2 CHOLESTEROL [J].
APPLEBAUMBOWDEN, D ;
HAFFNER, SM ;
HAZZARD, WR .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (10) :949-952
[6]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[7]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[8]   COMPARISON OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST PLUS TESTOSTERONE (T) VERSUS-T ALONE AS POTENTIAL MALE CONTRACEPTIVE REGIMENS [J].
BAGATELL, CJ ;
MATSUMOTO, AM ;
CHRISTENSEN, RB ;
RIVIER, JE ;
BREMNER, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :427-432
[9]   PHYSIOLOGICAL LEVELS OF ESTRADIOL STIMULATE PLASMA HIGH-DENSITY LIPOPROTEIN(2) CHOLESTEROL LEVELS IN NORMAL MEN [J].
BAGATELL, CJ ;
KNOPP, RH ;
RIVIER, JE ;
BREMNER, WJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04) :855-861
[10]   PHYSIOLOGICAL TESTOSTERONE LEVELS IN NORMAL MEN SUPPRESS HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL LEVELS [J].
BAGATELL, CJ ;
KNOPP, RH ;
VALE, WW ;
RIVIER, JE ;
BREMNER, WJ .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (12) :967-973